BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
about
Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancerBrain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated TumorigenesisBEX1 promotes imatinib-induced apoptosis by binding to and antagonizing BCL-2Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapyA feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer.Brain expressed and X-linked (Bex) proteins are intrinsically disordered proteins (IDPs) and form new signaling hubs.Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancerNotch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity.Interleukin-1β enhances cell migration through AP-1 and NF-κB pathway-dependent FGF2 expression in human corneal endothelial cells.Nerve growth factor in cancer cell death and survival.Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition.BEX2 promotes tumor proliferation in colorectal cancer.Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway.Bex2 is critical for migration and invasion in malignant glioma cells.BEX4 upregulation alters Sertoli cell growth properties and protein expression profiles: An explanation for cadmium-induced testicular Sertoli cell injury.C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer.A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
P2860
Q21195199-D80EEDA7-2D60-4332-BF8B-9C335441FCB4Q28393897-D70C10C8-FF96-458E-BD59-FFB4931E0559Q31153995-9E4DEECB-662C-4270-85A4-F1A7C56255B0Q33955386-40CD312F-B942-4D6B-AE8F-91C3AEDD195AQ34551559-3ACCF2DA-D6D3-46C4-93CE-A3C4226A473CQ35547360-D1E54639-E8E1-4220-A183-2AC53EB992E6Q35949760-D2C58B9B-07C4-4120-8D71-F2C1A268E9DDQ36021715-A9B4553C-A9FB-4D8D-BFC7-EADA8270ECEEQ36745414-619F8C23-CC8C-4C68-80BF-559F3619F91FQ37129797-E5D5D7E9-30F7-4AC5-B571-AE2F31091772Q37412510-CC1F7AED-70DE-4831-8AD4-82096930DE13Q37726221-39A76FF6-9B79-492D-84E9-0C8507EB016BQ39037261-A20D98E7-5F4C-4EEE-B261-0B9FBBE2B79CQ39294177-6FEAAE42-D4A7-4E32-AC0F-C21F981CDDF7Q40036297-8980660C-0426-4B66-BB58-EE747BD09B7DQ41339016-3B6DA9CB-9558-40A2-B9A2-0A829CFED526Q53262757-F29A6387-6D3A-4D50-9CDC-CB61C1A1751B
P2860
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
@ast
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
@en
type
label
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
@ast
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
@en
prefLabel
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
@ast
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
@en
P2860
P356
P1433
P1476
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
@en
P2093
Luke Hughes-Davies
P2860
P2888
P356
10.1186/1476-4598-9-111
P50
P577
2010-05-19T00:00:00Z
P5875
P6179
1000840619